KALA News and Press, Kala Pharmaceuticals Inc. From 10/29/20

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report third quarter 2020 financial results on Thursday, November 5, 2020. Mana...

Kala Pharmaceuticals on the go with upcoming PDUFA. Kezar announces Phase 2 KZR-616 trial update for polymyositis and dermatomyositis. Mirati Therapeutics announces positive clinical data for adagrasib. For further details see: Kala PDUFA, And Other News: The Good, Bad A...

Shares of Kala Pharmaceuticals (NASDAQ: KALA) were sinking 17.4% as of 3:30 p.m. EDT on Tuesday. The big drop came after the drugmaker announced FDA approval of Eysuvis for the short-term treatment of dry eye disease. Aren't biotech stocks supposed to go up when they win FDA...

Gainers: Scholar Rock (SRRK) +87%.Weidai (WEI) +60%.1847 Goedeker (GOED) +43%.Harley-Davidson (HOG) +27%.Synalloy (SYNL) +25%.Exact Sciences (EXAS) +22%.Harbor Custom Development (HCDI) +21%.TuanChe (TC) +20%.Unifi (UFI) +19%.CASI Pharmaceuticals (CASI) +18%.Losers: Cataba...

Gainers: Scholar Rock Holding (SRRK) +80%, Exact Sciences (EXAS) +18%, CHF Solutions (CHFS) +17%, CASI Pharmaceuticals (CASI) +13%, Prelude Therapeutics (PRLD) +8%.Losers: Catabasis Pharmaceuticals (CATB) -68%, Galera Therapeutics (GRTX)&...

The FDA has approved Kala Pharmaceuticals' (KALA) EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.“The FDA approval of EYSUVIS as the first prescription therapy specifically develope...

-- First Approved Prescription Therapy Specifically for Short-Term Treatment of Dry Eye Disease -- -- First Ocular Corticosteroid Indicated for Dry Eye Disease -- -- Kala to Host Conference Call Today at 8:30 a.m. ET -- Kala Pharmaceuticals, Inc. (NASDAQ:...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Gainers:  Immunomedics (NASDAQ: IMMU ) +100% . More news on: Immunomedics, Inc., Cassava Sciences, Inc., Vaxart, Inc., Stocks on the move, , Read more ...